22-23767401-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_213720.3(CHCHD10):c.234G>A(p.Ser78Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0103 in 1,608,354 control chromosomes in the GnomAD database, including 89 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0073 ( 5 hom., cov: 33)
Exomes 𝑓: 0.011 ( 84 hom. )
Consequence
CHCHD10
NM_213720.3 synonymous
NM_213720.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.35
Genes affected
CHCHD10 (HGNC:15559): (coiled-coil-helix-coiled-coil-helix domain containing 10) This gene encodes a mitochondrial protein that is enriched at cristae junctions in the intermembrane space. It may play a role in cristae morphology maintenance or oxidative phosphorylation. Mutations in this gene cause frontotemporal dementia and/or amyotrophic lateral sclerosis-2. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 7 and 19. [provided by RefSeq, Aug 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 22-23767401-C-T is Benign according to our data. Variant chr22-23767401-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 473423.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-23767401-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-2.35 with no splicing effect.
BS2
High AC in GnomAd4 at 1113 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHCHD10 | NM_213720.3 | c.234G>A | p.Ser78Ser | synonymous_variant | 2/4 | ENST00000484558.3 | NP_998885.1 | |
CHCHD10 | NM_001301339.2 | c.234G>A | p.Ser78Ser | synonymous_variant | 2/4 | NP_001288268.1 | ||
CHCHD10 | NR_125755.2 | n.279G>A | non_coding_transcript_exon_variant | 2/4 | ||||
CHCHD10 | NR_125756.2 | n.139+433G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHCHD10 | ENST00000484558.3 | c.234G>A | p.Ser78Ser | synonymous_variant | 2/4 | 1 | NM_213720.3 | ENSP00000418428.3 | ||
CHCHD10 | ENST00000401675.7 | c.234G>A | p.Ser78Ser | synonymous_variant | 2/4 | 5 | ENSP00000384973.3 | |||
CHCHD10 | ENST00000520222.1 | c.41+433G>A | intron_variant | 3 | ENSP00000430042.1 | |||||
CHCHD10 | ENST00000517886.1 | n.181G>A | non_coding_transcript_exon_variant | 2/4 | 3 | ENSP00000429976.1 |
Frequencies
GnomAD3 genomes AF: 0.00732 AC: 1113AN: 152096Hom.: 5 Cov.: 33
GnomAD3 genomes
AF:
AC:
1113
AN:
152096
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00740 AC: 1744AN: 235754Hom.: 13 AF XY: 0.00753 AC XY: 977AN XY: 129802
GnomAD3 exomes
AF:
AC:
1744
AN:
235754
Hom.:
AF XY:
AC XY:
977
AN XY:
129802
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0106 AC: 15501AN: 1456140Hom.: 84 Cov.: 36 AF XY: 0.0104 AC XY: 7562AN XY: 724162
GnomAD4 exome
AF:
AC:
15501
AN:
1456140
Hom.:
Cov.:
36
AF XY:
AC XY:
7562
AN XY:
724162
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00731 AC: 1113AN: 152214Hom.: 5 Cov.: 33 AF XY: 0.00720 AC XY: 536AN XY: 74420
GnomAD4 genome
AF:
AC:
1113
AN:
152214
Hom.:
Cov.:
33
AF XY:
AC XY:
536
AN XY:
74420
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 28, 2018 | This variant is associated with the following publications: (PMID: 27095681, 25726362) - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | CHCHD10: BP4, BP7, BS1, BS2 - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:2
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | - | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 11, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
CHCHD10-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 13, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Lower motor neuron syndrome with late-adult onset;C4014648:Frontotemporal dementia and/or amyotrophic lateral sclerosis 2;C4015513:Autosomal dominant mitochondrial myopathy with exercise intolerance Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at